Product image of Lactulose Eg (Lactulose) supplied by GNH India

Lactulose Eg

Active Ingredient:
Lactulose
Origin:
EU

Lactulose Eg (Lactulose)

Lactulose, the active ingredient in Lactulose Eg, is an osmotic laxative presented as an oral solution for oral use. It is employed to relieve constipation and to lower intestinal ammonia levels in patients with hepatic encephalopathy. The agent works by increasing osmotic pressure in the colon, drawing water into the lumen and facilitating bowel movements while also reducing ammonia absorption from the gut.

GNH India supplies Lactulose Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides batch‑tested product for global distribution.

Manufacturer / TM Owner

Eurogenerics N.V./S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lactulose is used to manage conditions within the gastrointestinal and hepatic disorder families.

  • Constipation: Relieves infrequent or hard stools by increasing water content in the colon.
  • Hepatic encephalopathy: Lowers blood ammonia levels, helping to improve mental status in liver disease patients.
  • Prevention of hepatic encephalopathy recurrence: Maintains reduced ammonia levels to reduce the risk of symptom return.

How It Works

  • Lactulose is a disaccharide that is not absorbed in the small intestine. In the colon it is metabolised by bacterial flora into short‑chain fatty acids, which increase the osmotic pressure and draw water into the lumen, softening stool and stimulating peristalsis. The acidic environment also converts ammonia to ammonium, reducing its absorption and lowering systemic ammonia concentrations.

Side Effects

Lactulose may cause a range of adverse reactions, most of which are related to its osmotic activity in the gut.

Common Side Effects

  • Bloating: Sensation of abdominal fullness.
  • Flatulence: Increased intestinal gas.
  • Abdominal cramps: Mild to moderate cramping sensations.
  • Diarrhea: Loose stools, especially with higher doses.
  • Nausea: Mild queasiness.

Serious or Rare Side Effects

  • Severe electrolyte imbalance: Notably low potassium or sodium levels.
  • Dehydration: Excess fluid loss leading to reduced hydration.
  • Allergic reaction: Rash, itching, or swelling of the face and throat.
  • Severe abdominal pain: Persistent or worsening pain requiring medical attention.
  • Hypernatremia: Elevated blood sodium from excessive fluid shifts.

Precautions & Warnings

When prescribing Lactulose, clinicians should consider several safety measures to minimize risk.

  • Dose adjustment in renal impairment: Reduce dose if creatinine clearance is markedly decreased.
  • Monitor electrolytes: Check serum potassium and sodium during prolonged therapy.
  • Caution in diabetes: Observe blood glucose as lactulose may affect carbohydrate balance.
  • Avoid abrupt discontinuation: Taper the dose to prevent rebound constipation.
  • Pregnancy and lactation: Use only if the potential benefit outweighs risk; consult a specialist.
  • Store at ambient temperature: Keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Lactulose can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Concurrent use with strong laxatives (e.g., senna): May cause excessive fluid loss and electrolyte disturbances.
  • Co‑administration with antidiarrheal agents (e.g., loperamide): Reduces lactulose’s intended laxative effect.

Moderate Interactions (Monitor Closely)

  • Mineral supplements (magnesium, calcium): May bind lactulose and diminish its osmotic action.
  • Antacids containing aluminum or magnesium: Can interfere with lactulose absorption.
  • Probiotic preparations: May modify gut flora and affect ammonia‑lowering efficacy.

Frequently Asked Questions

Lactulose Eg is indicated for the relief of constipation and for the treatment and prevention of hepatic encephalopathy, a neuropsychiatric complication of severe liver disease caused by elevated blood ammonia.

Lactulose is metabolised by colonic bacteria into short‑chain fatty acids, which increase osmotic pressure, draw water into the bowel, and lower the pH. This softens stool and promotes bowel movements while converting ammonia to non‑absorbable ammonium, thereby reducing systemic ammonia levels.

The prescribed dose of Lactulose Eg is individualized by the treating clinician based on the patient’s condition, severity, and response. Dosage adjustments are made according to clinical guidelines and patient monitoring.

Safety data for Lactulose in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the Lactulose Eg product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike stimulant laxatives, Lactulose is an osmotic agent that draws water into the colon without stimulating intestinal muscle directly. It also has the unique ability to lower intestinal ammonia, making it the preferred choice for patients with hepatic encephalopathy, whereas stimulant laxatives lack this effect.

Lactulose Eg should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight and extreme temperature fluctuations to maintain its stability.

Lactulose Eg is taken orally, usually as a liquid solution. It can be measured with a calibrated dosing device and mixed with water or another suitable beverage if desired. Administration should follow the prescriber’s instructions regarding timing and dose.

Serious risks include severe electrolyte disturbances, dehydration, and rare allergic reactions such as rash or facial swelling. Patients should be monitored for signs of these events, especially during high‑dose or prolonged therapy.

Lactulose Eg is contraindicated in patients with known hypersensitivity to lactulose or any of its excipients. Caution is advised in individuals with severe renal impairment, intestinal obstruction, or acute abdominal conditions, where use may be inappropriate.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.